Studies have shown that IGFBP7 is important for clinical staging of sepsis-related acute kidney injury (Molinari et al., 2022) because IGFBP7 can delay the progression of acute kidney injury by inhibiting RNF4/PARP1-mediated tubular injury (Yu et al., 2022). The gene discussed is PARP1; the disease is acute kidney injury.